Legend Biotech Overview
Company Headquarters: New Jersey, US
Founded: 2014
Workforce: ~500
Company Working: Legend Biotech is a multinational biopharmaceutical company. The company has three core cell therapy platforms—CAR-T) T-cell receptor T-cell therapy (TCR-T), and allogeneic cell therapy. The company has been developing a strong pipeline of CAR-T products to treat solid and liquid tumors. Legend Biotech is utilizing the extensive cell therapy experience of its leaders and R & D staff, global clinical partners, and expanding research facilities. It is doing so to utilize the potential of cell therapy to treat diseases that are thought to be incurable, such as hematologic malignancies, solid tumors, infectious diseases, and autoimmune diseases
Strategy
Legend Biotech is focused on achieving its goal of developing innovative cellular therapies for various therapeutic areas. It is also focused on investing in research and development to enhance its product pipeline. The company focuses on partnering with leading clinicians in oncology and hematology to rapidly advance the pipeline product portfolio
